D12.3
Benign neoplasm of transverse colon
Clinical Classification Guidelines
Inclusion Terms
- Benign neoplasm of hepatic flexure
- Benign neoplasm of splenic flexure
Medical Intelligence & Overview
A benign neoplasm of the transverse colon, classified under ICD-10 code D12.3, refers to a non-cancerous growth that develops within the transverse portion of the large intestine. This condition involves the formation of abnormal tissue growths that typically do not spread to other parts of the body. The transverse colon is the middle section of the large intestine that crosses the abdomen, connecting the ascending and descending parts. Such benign tumors are often discovered during routine screenings or diagnostic procedures and generally have a good prognosis if monitored or treated appropriately.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal cell growth Chronic inflammation of the colon Diet high in processed or red meats and low in fiber Lifestyle factors such as smoking and alcohol consumption History of polyps or other benign growths in the colon Age-related changes, as the risk increases with advancing age
Key Symptoms: Often asymptomatic in early stages Change in bowel habits, such as increased frequency or constipation Rectal bleeding or blood in stool Abdominal discomfort or cramping Feeling of incomplete bowel evacuation Unexplained weight loss in some cases Distension or bloating in the abdomen
Diagnostic & Treatment
Diagnosis Path: Identification of a benign neoplasm in the transverse colon typically involves a combination of diagnostic tools, including:
Treatment Protocols: Management of benign neoplasms in the transverse colon can vary based on size, location, and potential for complications. Common options include:
Clinical Advice & FAQs
Billing Guidance
Is D12.3 a billable ICD-10 code?
Yes, D12.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D12.3?
Clinical documentation must specify the nature of Benign neoplasm of transverse colon and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
